Ross Muken
About Ross Muken
Ross Muken is the Chief Operating Officer and Chief Financial Officer at SOPHiA GENETICS, with extensive experience in equity research and management in the healthcare sector. He has held senior roles at various financial institutions and companies, including Deutsche Bank and Click Therapeutics.
Work at SOPHiA GENETICS
Ross Muken currently serves as the Chief Operating Officer at SOPHiA GENETICS, a position he has held since 2023. Prior to this role, he was the Chief Financial Officer at the same company, starting in 2021. His tenure at SOPHiA GENETICS has allowed him to leverage his extensive experience in financial management and operational leadership within the life sciences sector.
Education and Expertise
Ross Muken holds a Bachelor’s degree in Business Administration from Boston University, where he graduated magna cum laude. His academic background has provided him with a solid foundation in management principles, which he has applied throughout his career in finance and equity research. He has substantial operating experience in cyber and compliance within the life sciences and health technology sectors.
Background
Ross Muken began his career as a Mergers & Acquisitions Analyst at Bank of America Securities from 2001 to 2003. He transitioned into equity research, working at various prestigious firms including Deutsche Bank, Evercore, and Click Therapeutics. His experience spans over two decades in the finance and healthcare sectors, where he has held multiple leadership roles.
Achievements
Throughout his career, Ross Muken has been recognized as a top-ranked equity research analyst in Life Science Tools & Diagnostics, as well as Healthcare Technology & Distribution. He has covered more than 50 companies across various healthcare subsectors and has served as a partner and Senior Managing Director at Evercore/ISI Group, leading the healthcare services and technology equity research team.
Previous Positions
Before joining SOPHiA GENETICS, Ross Muken held several significant positions. He served as Chief Financial Officer and Chief Operating Officer at Click Therapeutics from 2019 to 2021. Prior to that, he was a Senior Managing Director and Partner at Evercore from 2012 to 2019. His roles at Deutsche Bank included Vice President and Director of Equity Research, where he spent a total of seven years.